These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 19843084

  • 1. A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis.
    Tan WP, Suresh S, Tey HL, Chiam LY, Goon AT.
    Clin Exp Dermatol; 2010 Jun; 35(4):e109-12. PubMed ID: 19843084
    [Abstract] [Full Text] [Related]

  • 2. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study.
    Grimalt R, Mengeaud V, Cambazard F, Study Investigators' Group.
    Dermatology; 2007 Jun; 214(1):61-7. PubMed ID: 17191050
    [Abstract] [Full Text] [Related]

  • 3. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
    Peserico A, Städtler G, Sebastian M, Fernandez RS, Vick K, Bieber T.
    Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R, Matthews S, Arshad SH, McDonald S, Robinson J, Schapira C, Foote KD, Baird-Snell M, Gregory T, Pollock I, Stevens MT, Edwards AM.
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [Abstract] [Full Text] [Related]

  • 5. Long-term emollient therapy improves xerosis in children with atopic dermatitis.
    Boralevi F, Saint Aroman M, Delarue A, Raudsepp H, Kaszuba A, Bylaite M, Tiplica GS.
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1456-62. PubMed ID: 24267728
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
    Herzog JL, Solomon JA, Draelos Z, Fleischer A, Stough D, Wolf DI, Abramovits W, Werschler W, Green E, Duffy M, Rothaul A, Tansley R.
    J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
    [Abstract] [Full Text] [Related]

  • 7. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 8. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, Yi D, Zhao B.
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E, US Tacrolimus Ointment Study Group.
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Hon KL, Leung TF, Ng PC, Lam MC, Kam WY, Wong KY, Lee KC, Sung YT, Cheng KF, Fok TF, Fung KP, Leung PC.
    Br J Dermatol; 2007 Aug; 157(2):357-63. PubMed ID: 17501956
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [Abstract] [Full Text] [Related]

  • 12. An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis.
    Mengeaud V, Phulpin C, Bacquey A, Boralevi F, Schmitt AM, Taieb A.
    Pediatr Dermatol; 2015 Nov; 32(2):208-15. PubMed ID: 25529232
    [Abstract] [Full Text] [Related]

  • 13. Lack of efficacy of topical furfuryl palmitate in pediatric atopic dermatitis: a randomized double-blind study.
    Tripodi S, Di Rienzo Businco A, Panetta V, Pingitore G, Volterrani A, Frediani T, Pelosi S, Miceli Sopo S.
    J Investig Allergol Clin Immunol; 2009 Nov; 19(3):204-9. PubMed ID: 19610263
    [Abstract] [Full Text] [Related]

  • 14. Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial.
    Meurer M, Eichenfield LF, Ho V, Potter PC, Werfel T, Hultsch T.
    J Dermatolog Treat; 2010 May; 21(3):157-66. PubMed ID: 20394491
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
    Eberlein B, Eicke C, Reinhardt HW, Ring J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
    [Abstract] [Full Text] [Related]

  • 16. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
    Leung DY, Hanifin JM, Pariser DM, Barber KA, Langley RG, Schlievert PM, Abrams B, Hultsch T.
    Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis.
    Siegfried E, Korman N, Molina C, Kianifard F, Abrams K.
    J Dermatolog Treat; 2006 Aug; 17(3):143-50. PubMed ID: 16854753
    [Abstract] [Full Text] [Related]

  • 18. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.
    Bissonnette R, Maari C, Provost N, Bolduc C, Nigen S, Rougier A, Seite S.
    J Cosmet Dermatol; 2010 Mar; 9(1):16-21. PubMed ID: 20367668
    [Abstract] [Full Text] [Related]

  • 19. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
    Spergel JM, Boguniewicz M, Paller AS, Hebert AA, Gallagher PR, McCormick C, Parneix-Spake A, Hultsch T.
    Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
    [Abstract] [Full Text] [Related]

  • 20. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH, Lee KH, Jautova J, Wohlrab J, Guettner A, Mizutani G, Hultsch T.
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.